SCHEMBL4070811

SCHEMBL4070811

COC(=O)C(=O)c1c[nH]c2c(-c3nc[nH]n3)ncc(OC)c12

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.42
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
KCNH2 Q12809 1/20 0.37
AAK1 Q2M2I8 1/20 0.30
SYK P43405 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13899210 0.79 CYP2C9 (0.44) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL13119403 0.79 CYP2C9 (0.57) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL1472512 0.79 CYP2C9 (0.38) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL1472515 0.79 CYP2C9 (0.43) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL1473243 0.79 CYP2C9 (0.39) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL3933553 0.78 CYP2C9 (0.43) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL1762967 0.78 CYP2C9 (0.43) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL3561045 0.74 CYP2C9 (0.35) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12751213 0.71 CYP2C9 (0.41) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL2213083 0.71 CYP2C9 (0.43) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013170-A1 4-SQUARYLPIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS Brystol-Myers Squibb Company (US) 2009-01-14 EP disclosed
WO-2007127731-A1 4-SQUARYLPIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-11-08 WO disclosed